Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy and Tolerability of No7 in Osteoarthritis of the Knee: A Double Blind, Randomized, Placebo Controlled Clinical Study

NCT03442153 is registered in ClinicalTrials.gov with Ambrosia - SupHerb Ltd. as lead sponsor.

NCT NCT03442153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03442153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy and Tolerability of No7 in Osteoarthritis of the Knee: A Double Blind, Randomized, Placebo Controlled Clinical Study
Lead sponsor
Ambrosia - SupHerb Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2018
Completion date
May 31, 2018
Enrollment
76 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee